Lista de obras - Stephen D Ryder - Dominio Público Uruguay

A world without hepatitis C.

artículo científico publicado en 2014

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

artículo científico publicado en 2014

Chronic hepatitis C - what do the new drugs offer and who should get them first?

artículo científico publicado en 2015

Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys

scientific article published in 2023

Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial

artículo científico publicado en 2013

Genotype 4 and the global challenge of hepatitis C treatment.

artículo científico publicado en 2016

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults ⬇️

artículo científico publicado el 1 de mayo de 2003

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.

artículo científico publicado en 2014

Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus ⬇️

artículo científico publicado el 1 de septiembre de 1995

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

artículo científico publicado en 2014

Implementation of the Lancet Standing Commission on Liver Disease in the UK.

artículo científico publicado en 2015

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.

artículo científico publicado en 2016

Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis

artículo científico publicado en 2014

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

artículo científico publicado en 2016

Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.

artículo científico publicado en 2014

New metrics for the Lancet Standing Commission on Liver Disease in the UK.

artículo científico publicado en 2016

Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells

artículo científico publicado el 16 de septiembre de 1992

Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts.

artículo científico publicado en 2014

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

artículo científico publicado en 2015

Prednisolone or pentoxifylline for alcoholic hepatitis

artículo científico publicado en 2015

Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals.

artículo científico publicado en 2016

Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified

artículo científico publicado en 2015

Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.

artículo científico

Screening for hepatocellular carcinoma: patient selection and perspectives

artículo científico publicado en 2017

Serum autoantibody measurement for the detection of hepatocellular carcinoma

artículo científico publicado en 2014

Strategies to manage hepatitis C virus (HCV) disease burden.

artículo científico publicado en 2014

The Effect of Lectins on Crypt Cell Proliferation in Organ Culture

artículo científico publicado el 1 de enero de 1998

The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial

artículo científico publicado en 2015

The hepatitis C revolution part 1: antiviral treatment options

artículo científico publicado en 2015

The hepatitis C revolution part 2: difficult-to-treat groups and experimental approaches.

artículo científico publicado en 2015

The long‐term management of patients with bleeding duodenal ulcers ⬇️

artículo científico publicado el 1 de junio de 1997

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

artículo científico publicado en 2014

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

artículo científico publicado en 2014

Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.

artículo científico publicado en 2016

Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate

artículo científico publicado el 1 de enero de 1992

World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013

scientific article published on 01 March 2014

Lista de obras de Stephen D Ryder

A world without hepatitis C.

Addressing liver disease in the UK: a blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

Chronic hepatitis C - what do the new drugs offer and who should get them first?

Exploring changing attitudes to non-invasive liver fibrosis tests in secondary care pathways: comparison of two national surveys

Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial

Genotype 4 and the global challenge of hepatitis C treatment.

Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults ⬇️

HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact.

Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus ⬇️

Historical epidemiology of hepatitis C virus (HCV) in selected countries.

Implementation of the Lancet Standing Commission on Liver Disease in the UK.

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.

Lack of efficacy of an inhibitor of PDE4 in phase 1 and 2 trials of patients with nonalcoholic steatohepatitis

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal-An Evidence Review Group Perspective.

Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.

New metrics for the Lancet Standing Commission on Liver Disease in the UK.

Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells

Prediction of liver disease in patients whose liver function tests have been checked in primary care: model development and validation using population-based observational cohorts.

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

Prednisolone or pentoxifylline for alcoholic hepatitis

Prevention of progression to cirrhosis in hepatitis C with fibrosis: effectiveness and cost effectiveness of sequential therapy with new direct-acting anti-virals.

Response from Hepatitis C Trust, BASL, BIA, BVHG, BSG, and BHIVA to article asking whether widespread screening for hepatitis C is justified

Review article: 2014 UK consensus guidelines - hepatitis C management and direct-acting anti-viral therapy.

Screening for hepatocellular carcinoma: patient selection and perspectives

Serum autoantibody measurement for the detection of hepatocellular carcinoma

Strategies to manage hepatitis C virus (HCV) disease burden.

The Effect of Lectins on Crypt Cell Proliferation in Organ Culture

The clinical effectiveness and cost-effectiveness of STeroids Or Pentoxifylline for Alcoholic Hepatitis (STOPAH): a 2 × 2 factorial randomised controlled trial

The hepatitis C revolution part 1: antiviral treatment options

The hepatitis C revolution part 2: difficult-to-treat groups and experimental approaches.

The long‐term management of patients with bleeding duodenal ulcers ⬇️

The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm

Twenty-eight day safety, antiviral activity, and pharmacokinetics of tenofovir alafenamide for treatment of chronic hepatitis B infection

Urinary Metabotyping of Hepatocellular Carcinoma in a UK Cohort Using Proton Nuclear Magnetic Resonance Spectroscopy.

Use of an ammonia electrode for rapid quantification of Helicobacter pylori urease: its use in the endoscopy room and in the assessment of urease inhibition by bismuth subsalicylate

World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013